Dysregulated circulating miRNAs in preeclampsia

2013, Task Force on Hypertension in Pregnancy: Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122

Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726

Duley, 2009, The global impact of pre-eclampsia and eclampsia, Semin Perinatol, 33, 130, 10.1053/j.semperi.2009.02.010

2000, Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, Am J Obstet Gynecol, 183, S1, 10.1067/mob.2000.107928

Sibai, 2005, Pre-eclampsia, Lancet, 365, 785, 10.1016/S0140-6736(05)71003-5

Huppertz, 2008, Placental origins of preeclampsia: Challenging the current hypothesis, Hypertension, 51, 970, 10.1161/HYPERTENSIONAHA.107.107607

Foidart, 2009, Defective placental implantation and its effects on maternal endothelial function, Bull Acad Natl Med, 193, 1059

Foidart, 2009, Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer, J Reprod Immunol, 82, 106, 10.1016/j.jri.2009.09.001

Redman, 2014, IFPA Senior Award Lecture: Making sense of pre-eclampsia - two placental causes of preeclampsia?, Placenta, 35, S20, 10.1016/j.placenta.2013.12.008

Munaut, 2008, Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast, Hum Reprod, 23, 1407, 10.1093/humrep/den114

Roberts, 2009, The two stage model of preeclampsia: Variations on the theme, Placenta, 30, S32, 10.1016/j.placenta.2008.11.009

Redman, 2010, Immunology of pre-eclampsia, Am J Reprod Immunol, 63, 534, 10.1111/j.1600-0897.2010.00831.x

Dechend, 2012, Placenta messages to the mother: Not just debris, Hypertension, 59, 191, 10.1161/HYPERTENSIONAHA.111.184861

Bartel, 2009, MicroRNAs: Target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002

Lai, 2002, Micro RNAs are complementary to 3 UTR sequence motifs that mediate negative post-transcriptional regulation, Nat Genet, 30, 363, 10.1038/ng865

Weber, 2010, The microRNA spectrum in 12 body fluids, Clin Chem, 56, 1733, 10.1373/clinchem.2010.147405

Ong, 2015, MicroRNA-mediated regulation of differentiation and trans-differentiation in stem cells, Adv Drug Deliv Rev, 88, 3, 10.1016/j.addr.2015.04.004

Miura, 2010, Identification of pregnancy-associated microRNAs in maternal plasma, Clin Chem, 56, 1767, 10.1373/clinchem.2010.147660

Tsochandaridis, 2015, Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications, BioMed Res Int, 2015, 294954, 10.1155/2015/294954

Li, 2013, Maternal plasma miRNAs expression in preeclamptic pregnancies, Biomed Res Int, 2013, 970265, 10.1155/2013/970265

Wu, 2012, Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies, Reproduction, 143, 389, 10.1530/REP-11-0304

Gunel, 2011, Serum microRNA expression in pregnancies with preeclampsia, Genet Mol Res, 10, 4034, 10.4238/2011.November.8.5

Ura, 2014, Potential role of circulating microRNAs as early markers of preeclampsia, Taiwan J Obstet Gynecol, 53, 232, 10.1016/j.tjog.2014.03.001

Zhang, 2010, Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases, Clin Chem, 56, 1830, 10.1373/clinchem.2010.147850

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262

Kok, 2015, Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR, FASEB J, 29, 3853, 10.1096/fj.15-271312

Hanley, 1982, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, 143, 29, 10.1148/radiology.143.1.7063747

Zhao, 2013, Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases, Clin Biochem, 46, 953, 10.1016/j.clinbiochem.2013.01.026

Chen, 2009, Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis, BMC Genomics, 10, 407, 10.1186/1471-2164-10-407

Sato, 2009, Intra-platform repeatability and inter-platform comparability of microRNA microarray technology, PLoS One, 4, e5540, 10.1371/journal.pone.0005540

Roberts, 2014, Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum, PLoS One, 9, e89237, 10.1371/journal.pone.0089237

Anton, 2013, miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia, Am J Pathol, 183, 1437, 10.1016/j.ajpath.2013.07.021

Pineles, 2007, Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia, Am J Obstet Gynecol, 196, 261.e1, 10.1016/j.ajog.2007.01.008

Enquobahrie, 2011, Placental microRNA expression in pregnancies complicated by preeclampsia, Am J Obstet Gynecol, 204, 178.e12, 10.1016/j.ajog.2010.09.004

Muralimanoharan, 2012, miR-210 modulates mitochondrial respiration in placenta with preeclampsia, Placenta, 33, 816, 10.1016/j.placenta.2012.07.002

Zhang, 2012, Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: New insights into molecular mechanisms for the disease, J Cell Mol Med, 16, 249, 10.1111/j.1582-4934.2011.01291.x

Camps, 2008, hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer, Clin Cancer Res, 14, 1340, 10.1158/1078-0432.CCR-07-1755

Fasanaro, 2008, MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3, J Biol Chem, 283, 15878, 10.1074/jbc.M800731200

Wulfken, 2011, MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels, PLoS One, 6, e25787, 10.1371/journal.pone.0025787

Lewis, 2003, Prediction of mammalian microRNA targets, Cell, 115, 787, 10.1016/S0092-8674(03)01018-3

Grill, 2009, Potential markers of preeclampsia-a review, Reprod Biol Endocrinol, 7, 70, 10.1186/1477-7827-7-70

Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling, Health Technol Assess, 12, 1, 10.3310/hta12060

Zakiyah, 2015, IMPROvED Consortium: Pre-eclampsia diagnosis and treatment options: A review of published economic assessments, Pharmacoeconomics, 33, 1069, 10.1007/s40273-015-0291-x

Poon, 2010, Hypertensive disorders in pregnancy: Combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11–13 weeks, Prenat Diagn, 30, 216, 10.1002/pd.2440

Poon, 2009, First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia, Ultrasound Obstet Gynecol, 33, 23, 10.1002/uog.6280

Scazzocchio, 2013, Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting, Am J Obstet Gynecol, 208, 203.e1, 10.1016/j.ajog.2012.12.016

Park, 2013, Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy, Aust N Z J Obstet Gynaecol, 53, 532, 10.1111/ajo.12126

Akolekar, 2013, Competing risks model in early screening for preeclampsia by biophysical and biochemical markers, Fetal Diagn Ther, 33, 8, 10.1159/000341264

Akolekar, 2011, Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks, Prenat Diagn, 31, 66, 10.1002/pd.2660

Foidart, 2010, Maternal plasma soluble endoglin at 11–13 weeks' gestation in pre-eclampsia, Ultrasound Obstet Gynecol, 35, 680, 10.1002/uog.7621

Kusanovic, 2009, A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia, J Matern Fetal Neonatal Med, 22, 1021, 10.3109/14767050902994754

Lycoudi, 2015, miRNAs in pregnancy-related complications, Expert Rev Mol Diagn, 15, 999, 10.1586/14737159.2015.1053468

Morales, 2011, MicroRNAs in pregnancy, J Reprod Immunol, 88, 106, 10.1016/j.jri.2011.01.004